AZURE Study
A Phase 3 study investigating whether an investigational medication can reduce the risk of heart attack or stroke in adults with cardiovascular disease or at high risk. Compensation up to $1,600.
Study Category: Cardiovascular Health
A Phase 3 study investigating whether an investigational medication can reduce the risk of heart attack or stroke in adults with cardiovascular disease or at high risk. Compensation up to $1,600.